IN BRIEF (Page 16)
China Daily | Updated: 2009-03-27 07:45
Roche gets control
Swiss drugmaker Roche Holding AG said yesterday it controlled a total of 96.2 percent of Genentech shares after completing its tender offer for the 44 percent stake it did not already own.
Roche said remaining holders of Genentech shares would revive $95 a share. Genentech will cease to be traded on the New York Stock Exchange, Roche said.
Photo
